Tilray Brands (NASDAQ:TLRY) Stock Falls 1.4% After Analyst Downgrade

Key Points

• Tilray shares fell 1.4% after Canaccord Genuity cut its price target from $4.50 to $4.00 while maintaining a Hold rating. The stock traded near $3.54 on heavier-than-average volume.
• Analyst sentiment remains mixed but cautious: Tilray has a consensus Hold rating and an average price target of $5.90, while several firms recently lowered targets or downgraded the stock.
• The company is showing strong growth in beverages and international operations, but profitability and declining Canadian cannabis sales remain concerns. CFO Carl Merton recently bought 10,000 shares, and insiders have purchased 15,000 shares over the past 90 days.

Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) shares were down 1.4% during trading on Friday after Canaccord Genuity Group lowered their price target on the stock from $4.50 to $4.00. Canaccord Genuity Group currently has a hold rating on the stock. Tilray Brands traded as low as $3.39 and last traded at $3.54. Approximately 5,584,117 shares changed hands during mid-day trading, an increase of 32% from the average session volume of 4,240,514 shares. The stock had previously closed at $3.59.

A number of other equities analysts also recently issued reports on the company. Weiss Ratings downgraded Tilray Brands from a "sell (d-)" rating to a "sell (e+)" rating in a report on Monday, September 21st. ATB Cormark Capital Markets cut their price objective on shares of Tilray Brands from $8.00 to $6.00 and set a "hold" rating on the stock in a report on Monday, September 21st. Wall Street Zen downgraded shares of Tilray Brands from a "hold" rating to a "sell" rating in a research report on Saturday, August 1st. TD lowered their target price on shares of Tilray Brands from $4.70 to $4.50 and set a "buy" rating for the company in a report on Monday. Finally, TD Securities upgraded shares of Tilray Brands to a "strong-buy" rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $5.90.

Insider Buying and Selling at Tilray Brands

In other news, CFO Carl Merton bought 10,000 shares of Tilray Brands stock in a transaction dated Tuesday, August 4th. The stock was acquired at an average cost of $4.62 per share, with a total value of $46,200.00. Following the acquisition, the chief financial officer owned 139,753 shares of the company's stock, valued at approximately $645,658.86. This trade represents a 7.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last ninety days, insiders bought 15,000 shares of company stock valued at $69,225. 1.60% of the stock is currently owned by insiders.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray reported fiscal Q1 2027 revenue of approximately $257.1 million, up 23% year over year, while gross profit increased 35% to $77.5 million and gross margin expanded to 30%. The company reaffirmed its fiscal 2027 adjusted EBITDA outlook of $68 million to $75 million. Tilray Brands Q1 Fiscal 2027 Results
• Positive Sentiment: Growth is becoming less dependent on potential U.S. cannabis reform. Beverage revenue rose 82% to about $101 million, BrewDog reached profitability, and EMEA revenue grew 71%, led by medical cannabis and pharmaceutical distribution. Tilray also reduced debt by $42 million during the fiscal year and ended the quarter with a net-cash position. Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
• Neutral Sentiment: Options-market commentary points to expectations for a near-term rebound following earnings, but this represents positioning and sentiment rather than a fundamental improvement. Following Tilray Earnings, Here's What Comes Next for TLRY Stock
• Negative Sentiment: Tilray posted an adjusted loss of roughly $0.32 per share, worse than the $0.19 consensus loss cited by Zacks, while quarterly revenue fell short of analyst expectations near $266 million. The results renewed concerns about profitability despite strong headline sales growth. Tilray Reports Q1 Loss
• Negative Sentiment: Declining Canadian cannabis sales are weighing on investor confidence, as beverage and international growth have not yet fully offset weakness in Tilray’s core cannabis business. Canaccord Genuity lowered its price target from $4.50 to $4.00 and maintained a Hold rating, signaling limited conviction in a sustained recovery. Tilray Shares Under Pressure as Cannabis Sales Decline

Institutional Investors Weigh In On Tilray Brands

Several large investors have recently modified their holdings of the company. Hilton Head Capital Partners LLC acquired a new position in Tilray Brands in the 4th quarter valued at about $38,000. Pictet Asset Management Holding SA lifted its position in Tilray Brands by 38.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company's stock worth $119,000 after acquiring an additional 5,145 shares during the period. Integrated Wealth Concepts LLC purchased a new position in shares of Tilray Brands in the 2nd quarter valued at approximately $27,000. Baader Bank Aktiengesellschaft grew its stake in shares of Tilray Brands by 17.7% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company's stock valued at $293,000 after purchasing an additional 7,226 shares during the last quarter. Finally, Essential Partners LLC increased its holdings in shares of Tilray Brands by 110,137.5% in the first quarter. Essential Partners LLC now owns 8,819 shares of the company's stock valued at $57,000 after purchasing an additional 8,811 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Brands Stock Performance

The company has a quick ratio of 1.37, a current ratio of 2.21 and a debt-to-equity ratio of 0.22. The stock has a fifty day moving average price of $4.31 and a 200-day moving average price of $5.03. The firm has a market cap of $482.16 million, a price-to-earnings ratio of -3.28 and a beta of 1.91.

Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.42). The company had revenue of $281.71 million for the quarter, compared to analyst estimates of $246.30 million. Tilray Brands had a negative return on equity of 7.76% and a negative net margin of 13.11%. On average, analysts expect that Tilray Brands, Inc. will post -0.48 earnings per share for the current fiscal year.

About Tilray Brands

Tilray Brands, Inc is a global consumer packaged goods company focused on cannabis, beverage alcohol, wellness and consumer products. The company develops, produces, distributes and markets a range of cannabis products, including dried flower, pre-rolls, vapes, edibles and medical cannabis products, subject to applicable regulations in the markets it serves.

Tilray also operates beverage alcohol businesses, including craft beer, spirits and other alcoholic beverages. Its portfolio has included brands such as SweetWater Brewing Company, Montauk Brewing Company and Breckenridge Distillery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.